FINWIRES · TerminalLIVE
FINWIRES

Legacy Gold Mines股價上漲30%，接近52周高點，此前該公司透過非經紀人私募融資籌集了1000萬美元。

-- Legacy Gold Mines (LEGY.V) 週四股價上漲 30%，接近 52 週高點，此前該公司完成了此前宣布的 1000 萬美元非經紀人私募配售。 該公司表示，此次發行包括以每股 0.30 美元的價格發行 3,330 萬股普通股。私募配售完成後，由 Wexford Capital LP 管理的基金合計持有約 15% 的已發行流通普通股。 所得將用於推進其位於愛達荷州奧羅格蘭德礦區的 Baner 金礦項目的鑽探和開發活動，以及業務拓展和一般行政開支。該公司已同意向佛羅裡達州的 John Tumazos 發行 825,490 股普通股，佔此次私募配售中由他介紹的認購者所售普通股的 3%。 該公司還確認，已完成根據其購買該礦產項目100%權益選擇權支付的第二筆款項。該選擇權的最終付款將於2027年4月到期，包括50萬美元現金和20萬張可購買普通股的認股權證。 Legacy Gold Mines公司同時正在尋求多倫多證券交易所創業板（TSXV）的批准，將先前於2024年10月向Champion Electric公司發行的20萬份認股權證的有效期延長12個月。 在本次私募配售中，執行長Brian Hinchcliffe以13.56萬美元的總價購入了45.2萬股普通股，勘探副總裁兼公司董事Mike Sutton以10萬美元的價格購入了33.3333萬股普通股。 該股在多倫多證券交易所創業板 (TSXV) 最新上漲 0.14 美元至 0.60 美元，距離 52 週高點 0.63 美元仍有一定差距。

Price: $0.60, Change: $+0.14, Percent Change: +30.43%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB